Article: Nicotinamide Riboside Supplementation Enhances NAD+ Metabolism in Ataxia Telangiectasia: Clinical Findings

Nov 17, 2020 Ataxia Telangiectasia Clinical Neurological Health

Nicotinamide Riboside Supplementation Enhances NAD+ Metabolism in Ataxia Telangiectasia: Clinical Findings

Objectives

To study the metabolic effects of treatment with NR in a cohort of patients with ataxia-telangiectasia (AT).

Journal

Metabolites

Key Outcomes

NR-related pathways and metabolites significantly increased after NR supplementation.

Duration

4 months

Dose

25 mg/kg

Study Design

Comparative study in 14 patients with ataxia telangiectasia (AT)

See Published Study

Healthy Aging & Longevity

Cockayne Syndrome Proteins Maintain Mitochondrial Health Through NAD+ Signaling: Preclinical Findings

SynopsisCockayne syndrome (CS) is a rare premature aging disorder involving DNA repair defects and mitochondrial dysfunction. Across human, mouse, and nematode models, mitochondrial dysfunction was...

Metabolic Health

Nicotinamide Riboside Enhances Muscle Growth and Fiber Density in Chicken Embryos: Preclinical Findings

Synopsis Researchers injected nicotinamide riboside (NR) into fertilized chicken eggs to study its effects on muscle growth. NR increased the weight, length, and width of the pectoral muscles in c...